Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Plasma cell 1Head & Neck 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Smoldering Multiple Myeloma 1Salivary Gland Adenoma, Pleomorphic 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Monoclonal Gammopathy of Undetermined Significance 1Glioma 1Breast Neoplasms 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Urination × 1 year × Clear all
NCT03784924 2026-01-08

P-MRI

University of Michigan

Recruiting
950 enrolled
GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms

NCT06575452 2025-12-03

EPIGLIO

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Not yet recruiting
228 enrolled
CNS

Glioma

NCT03951220 2025-08-19

LOOMIS

Oxford University Hospitals NHS Trust

Completed
67 enrolled 24 charts
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Neoplasms, Plasma Cell

NCT03958136 2025-08-17

EPICURE_SEIN

Institut Cancerologie de l'Ouest

Phase NA Active not recruiting
289 enrolled
Breast

Breast Neoplasms

NCT03831230 2025-08-08

OVAREX

Centre Francois Baclesse

Completed
250 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡